Embecta Corp EMBC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
embecta to Participate in Investor Events
-
EMBC Stock News: Embecta Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 57% Stock Drop
-
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026
-
EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit
-
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law
-
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law
-
Embecta Corp. Sued for Securities Law Violations - FINAL DEADLINE TODAY - EMBC
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 56.66M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 4.57
- Price/Sales
- 0.37
- Dividend Yield (Trailing)
- 5.12%
- Dividend Yield (Forward)
- 0.64%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 5.12%
Company Profile
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,850
- Website
- https://www.embecta.com
Valuation
|
Metric
|
EMBC
|
|---|---|
Price/Earnings (Normalized) | 4.57 |
Price/Book Value | — |
Price/Sales | 0.37 |
Price/Cash Flow | 2.01 |
Price/Earnings
EMBC
Financial Strength
|
Metric
|
EMBC
|
|---|---|
Quick Ratio | 0.95 |
Current Ratio | 1.68 |
Interest Coverage | 2.29 |
Quick Ratio
EMBC
Profitability
|
Metric
|
EMBC
|
|---|---|
Return on Assets (Normalized) | 10.74% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 23.53% |
Return on Assets
EMBC
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|<<GqXT!X | LOCK|Yb | $153B | |||
| Becton Dickinson & Co
BDX
| LOCK|&!> | LOCK|#Ygk | $54B | |||
| Alcon Inc
ALC
| LOCK|b&lPF!$ | LOCK|Xr^% | $35B | |||
| ResMed Inc
RMD
| LOCK|h!rs@$lt | LOCK|%lQcj | $32B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|<cZLLwC | LOCK|&Z | $29B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|FX>HSH | LOCK|LFgX> | $28B | |||
| Solventum Corp
SOLV
| LOCK|rVQC#Kd | LOCK|cD! | $14B | |||
| Baxter International Inc
BAX
| LOCK|bv^ | LOCK|@>Pt | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|>HLZpn | LOCK|M!qX | $11B | |||
| Repligen Corp
RGEN
| LOCK|hMt>vvt | LOCK|%ZQ@v | $11B |
United States